Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 8 |
GO:0043226 | organelle | 2 | 8 |
GO:0043228 | non-membrane-bounded organelle | 3 | 8 |
GO:0043229 | intracellular organelle | 3 | 8 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: A4H5Z2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 63 | 67 | PF00656 | 0.693 |
CLV_NRD_NRD_1 | 153 | 155 | PF00675 | 0.590 |
CLV_NRD_NRD_1 | 179 | 181 | PF00675 | 0.430 |
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.685 |
CLV_PCSK_KEX2_1 | 179 | 181 | PF00082 | 0.430 |
CLV_Separin_Metazoa | 213 | 217 | PF03568 | 0.430 |
DOC_CKS1_1 | 166 | 171 | PF01111 | 0.537 |
DOC_PP1_RVXF_1 | 186 | 192 | PF00149 | 0.376 |
DOC_USP7_MATH_1 | 135 | 139 | PF00917 | 0.737 |
DOC_USP7_UBL2_3 | 106 | 110 | PF12436 | 0.702 |
DOC_USP7_UBL2_3 | 111 | 115 | PF12436 | 0.735 |
DOC_USP7_UBL2_3 | 220 | 224 | PF12436 | 0.385 |
DOC_USP7_UBL2_3 | 226 | 230 | PF12436 | 0.389 |
DOC_WW_Pin1_4 | 110 | 115 | PF00397 | 0.640 |
DOC_WW_Pin1_4 | 165 | 170 | PF00397 | 0.777 |
DOC_WW_Pin1_4 | 49 | 54 | PF00397 | 0.596 |
DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.736 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.665 |
LIG_FHA_1 | 129 | 135 | PF00498 | 0.711 |
LIG_FHA_2 | 58 | 64 | PF00498 | 0.618 |
LIG_LIR_Nem_3 | 177 | 181 | PF02991 | 0.724 |
LIG_SH2_SRC | 62 | 65 | PF00017 | 0.532 |
LIG_SH2_STAT3 | 46 | 49 | PF00017 | 0.718 |
LIG_SH2_STAT5 | 12 | 15 | PF00017 | 0.572 |
LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.466 |
LIG_SH2_STAT5 | 7 | 10 | PF00017 | 0.587 |
LIG_SH3_3 | 101 | 107 | PF00018 | 0.695 |
LIG_SH3_4 | 106 | 113 | PF00018 | 0.607 |
LIG_SxIP_EBH_1 | 77 | 86 | PF03271 | 0.791 |
LIG_TRAF2_1 | 201 | 204 | PF00917 | 0.249 |
MOD_CDK_SPK_2 | 110 | 115 | PF00069 | 0.697 |
MOD_CDK_SPxxK_3 | 79 | 86 | PF00069 | 0.709 |
MOD_CK1_1 | 128 | 134 | PF00069 | 0.792 |
MOD_CK2_1 | 247 | 253 | PF00069 | 0.633 |
MOD_Cter_Amidation | 140 | 143 | PF01082 | 0.702 |
MOD_Cter_Amidation | 34 | 37 | PF01082 | 0.719 |
MOD_GlcNHglycan | 107 | 110 | PF01048 | 0.607 |
MOD_GlcNHglycan | 137 | 140 | PF01048 | 0.813 |
MOD_GSK3_1 | 105 | 112 | PF00069 | 0.809 |
MOD_GSK3_1 | 124 | 131 | PF00069 | 0.625 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.765 |
MOD_N-GLC_1 | 174 | 179 | PF02516 | 0.697 |
MOD_N-GLC_1 | 57 | 62 | PF02516 | 0.651 |
MOD_NEK2_1 | 214 | 219 | PF00069 | 0.440 |
MOD_PKA_1 | 105 | 111 | PF00069 | 0.795 |
MOD_Plk_1 | 100 | 106 | PF00069 | 0.692 |
MOD_Plk_1 | 238 | 244 | PF00069 | 0.430 |
MOD_Plk_1 | 57 | 63 | PF00069 | 0.516 |
MOD_ProDKin_1 | 110 | 116 | PF00069 | 0.636 |
MOD_ProDKin_1 | 165 | 171 | PF00069 | 0.773 |
MOD_ProDKin_1 | 49 | 55 | PF00069 | 0.597 |
MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.733 |
TRG_DiLeu_BaEn_4 | 203 | 209 | PF01217 | 0.249 |
TRG_ER_diArg_1 | 178 | 180 | PF00400 | 0.677 |
TRG_Pf-PMV_PEXEL_1 | 22 | 27 | PF00026 | 0.749 |
TRG_Pf-PMV_PEXEL_1 | 37 | 41 | PF00026 | 0.361 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4J8F0 | Bodo saltans | 40% | 100% |
A0A1X0NQ23 | Trypanosomatidae | 48% | 100% |
A0A3S5H6F2 | Leishmania donovani | 74% | 98% |
A4HUB7 | Leishmania infantum | 74% | 98% |
E9AN16 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 75% | 99% |
Q4QHL0 | Leishmania major | 76% | 100% |